Neuraxis, INC
NRXS · XNYSCIK 1933567fmd_091RH02BG26XW86Q20FE9ACQG4Manufacturing · Electromedical & Electrotherapeutic ApparatusTemplate: Standard
Coverage: Jan 01, 2022 to Sep 30, 2026, 19 periods
| Line item | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
| Total revenues | 3 | 2 | 3 | 4 |
| Cost of revenue | 0 | 0 | 0 | 1 |
| Gross profit | 2 | 2 | 2 | 3 |
| Research and development | 0 | 0 | 0 | 0 |
| Operating income | (3) | (7) | (7) | (8) |
| Interest expense | 0 | 0 | 0 | 0 |
| Other non-operating income (expense) | (1) | (8) | (1) | 0 |
| Net income | (5) | (15) | (8) | (8) |
| Net income to common shareholders | (6) | (15) | (8) | (9) |